July 2019 |
|
Grassley’s Rx Bill Passes: “Unprecedented,” “Historic,” “Blockbuster,” “Tipping Point,” “Sweeping,” “Ambitious,” “Major”
|
|
Grassley Statement on Committee Passage of Prescription Drug Pricing Reduction Act
|
|
Grassley On The Prescription Drug Pricing Reduction Act of 2019
|
|
Stakeholder, Expert Endorsements Grow for Finance Committee Prescription Drug Legislation
|
|
Grassley On Tax Extenders Benefits
|
|
Grassley On Treasury, Tax Court Nominations
|
|
Grassley On USMCA Manufacturing
|
|
Support Rolls in for Finance Committee Prescription Drug Package
|
|
Grassley, Wyden Introduce Major Prescription Drug Pricing Reform to Lower Costs for Americans
|
|
For the Record: Grassley on Prescription Drug Pricing
|
|
Grassley On Elder Justice: A Call for Reform
|
|
ICYMI: Inside The Pharmaceutical Lobby's Campaign For More Government Subsidies Through Medicare Part D
|
|
ICYMI: Inside The Pharmaceutical Lobby's Campaign For More Government Subsidies Through Medicare Part D
|
|
Grassley, Wyden Seek Information on Appraiser Linked to Inflated Valuations and Massive Tax Breaks
|
|
Grassley At the Washington International Trade Association Awards Dinner
|